Epithelial dendritic cells vs. Langerhans cells: Implications for mucosal vaccines

Cell Rep. 2024 Apr 23;43(4):113977. doi: 10.1016/j.celrep.2024.113977. Epub 2024 Mar 20.

Abstract

Next-generation vaccines may be delivered via the skin and mucosa. The stratified squamous epithelium (SSE) represents the outermost layer of the skin (epidermis) and type II mucosa (epithelium). Langerhans cells (LCs) have been considered the sole antigen-presenting cells (APCs) to inhabit the SSE; however, it is now clear that dendritic cells (DCs) are also present. Importantly, there are functional differences in how LCs and DCs take up and process pathogens as well as their ability to activate and polarize T cells, though whether DCs participate in neuroimmune interactions like LCs is yet to be elucidated. A correct definition and functional characterization of APCs in the skin and anogenital tissues are of utmost importance for the design of better vaccines and blocking pathogen transmission. Here, we provide a historical perspective on the evolution of our understanding of the APCs that inhabit the SSE, including a detailed review of the most recent literature.

Keywords: CP: Immunology.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dendritic Cells* / immunology
  • Epithelial Cells / immunology
  • Humans
  • Langerhans Cells* / immunology
  • Mucous Membrane / cytology
  • Mucous Membrane / immunology
  • Skin / immunology
  • Vaccines* / immunology

Substances

  • Vaccines